AMERICAN INTERNATIONAL GROUP, INC. - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$132,000
-56.9%
27,214
-5.5%
0.00%0.0%
Q4 2019$306,000
+3.7%
28,785
+1.7%
0.00%0.0%
Q3 2019$295,000
-24.4%
28,303
+11.1%
0.00%
-50.0%
Q2 2019$390,000
+24.6%
25,472
+4.5%
0.00%
+100.0%
Q1 2019$313,000
+76.8%
24,385
+31.0%
0.00%0.0%
Q4 2018$177,000
-43.1%
18,614
-0.8%
0.00%0.0%
Q3 2018$311,000
+7.6%
18,757
+4.2%
0.00%0.0%
Q2 2018$289,000
+11.2%
18,003
+6.0%
0.00%0.0%
Q1 2018$260,000
+9.7%
16,978
+11.6%
0.00%0.0%
Q4 2017$237,000
+41.1%
15,211
+0.5%
0.00%0.0%
Q3 2017$168,000
+30.2%
15,138
+8.1%
0.00%
Q2 2017$129,000
+43.3%
14,007
+32.9%
0.00%
Q1 2017$90,000
-13.5%
10,543
+8.8%
0.00%
Q4 2016$104,000
-99.9%
9,693
-0.3%
0.00%
Q3 2016$105,257,000
+60.2%
9,719
+0.1%
0.00%
Q2 2016$65,703,000
+52.8%
9,705
+6.1%
0.00%
Q1 2016$43,000,000
-25.9%
9,1510.0%0.00%
Q4 2015$58,000,000
+71504.9%
9,151
-0.2%
0.00%
Q3 2015$81,000
-99.9%
9,167
+0.1%
0.00%
Q2 2015$107,778,000
+2.5%
9,157
+26.1%
0.00%
Q1 2015$105,110,000
-15.2%
7,2640.0%0.00%
-100.0%
Q4 2014$123,924,000
+31.7%
7,264
-3.8%
0.00%
Q3 2014$94,098,000
-15.1%
7,552
-0.1%
0.00%
Q2 2014$110,861,000
-22.6%
7,557
+7.4%
0.00%
-100.0%
Q1 2014$143,274,000
+14.6%
7,037
+10.3%
0.00%0.0%
Q4 2013$125,048,000
-57.1%
6,380
-0.8%
0.00%
-50.0%
Q3 2013$291,307,0006,4320.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders